PDA Universe of Pre-Filled Syringes and Injection Devices Conference 2026

We look forward to seeing you at PDA UPFS (PDA Universe of Pre-Filled Syringes and Injection Devices) – an event exploring the intersection of science, technology, patient experience and sustainability in injectable combination products.

Chris Hurlstone, John Burke, Thomas Grant and Alastair Willoughby will be at stand 111, happy to discuss how Team Consulting can help you develop complex, innovative and award-winning drug delivery devices.

We are excited to be both speaking and attending, sharing expertise and connecting with industry leaders at the event.

Book a meeting

Investigating imaging modalities to characterize injection deposition for LVSC device design

Date: Wednesday 7th October 2026
Time: 13:35 – 13:55

John Burke, Managing Consultant – Drug Delivery at Team, will be presenting alongside Alex Lyness, Head of Applied Research and Innovation Strategy at SHL Medical.

As subcutaneous (SC) delivery advances toward larger injection volumes and higher flow rates, there remains a fundamental need to empirically understand fluid distribution within SC tissue and the associated evolution of tissue resistance. Their presentation gives insight into:

  • The need for fit-for-purpose imaging methodologies when studying large-volume subcutaneous delivery (LVSC) fundamentals
  • How ex vivo porcine tissue models can be used to explore device–tissue interactions prior to in vivo evaluation
  • The relative utility, practicality and limitations of visual sectioning, ultrasound and micro-CT imaging for LVSC studies
  • Key device parameters, including volume, dispense rate and contact force, that warrant systematic investigation to inform LVSC autoinjector development
event-banner-1

From outsourcing to partnership: lessons from a strategic partnership in combination product development

Date: Tuesday 6th October 2026
Time: 15:40 – 15:50

Thomas Grant, Senior Digital Health Specialist at Team, will be presenting alongside Alasdair Young, Senior Director of Device Engineering at Gilead Sciences.

As pharmaceutical companies increasingly outsource combination product device development, success depends not only on technical capability, but on the quality of collaboration between internal teams and external partners. This presentation provides insight into:

  • How complementary expertise across pharmaceutical and development organisations can be aligned to deliver complex combination product programmes
  • The factors that enable outsourced development relationships to evolve into effective strategic partnerships
  • Practical approaches for managing geographically distributed teams, clarifying ownership and maintaining engagement across organisations
  • How governance structures, communication frameworks and “one team” behaviours can improve efficiency while maintaining quality, regulatory confidence and patient focus

How can we support you?

At Team Consulting, we have over 40 years of expertise in developing drug delivery products covering injection devices, implantable technologies, connected devices and more.

Contact us to discuss how we can address your device  development challenges.

Join the conversation

Looking for industry insights? Click below to get our opinions and thoughts into the world of
medical devices and healthcare.